南模生物(688265) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥87,997,218.63, representing a year-on-year increase of 0.90%[2]. - The net profit attributable to shareholders for Q3 2024 was -¥6,051,783.03, with a year-to-date net profit of -¥15,195,356.25, reflecting a decrease of 1.17% compared to the same period last year[2]. - The basic and diluted earnings per share for Q3 2024 were both -¥0.08, showing an improvement from -¥0.20 in the same period last year[2]. - Net profit for the first three quarters of 2024 was CNY -15,195,356.25, compared to CNY -14,611,743.83 in the same period of 2023, indicating a worsening of approximately 4.0%[19]. - The company reported a total revenue of CNY 264,848,483.40 for the first three quarters of 2024, down from CNY 267,990,100.50 in 2023, a decrease of approximately 1.6%[17]. - The total comprehensive income attributable to the parent company for the current period was approximately -¥15.42 million, compared to -¥13.80 million in the previous period, reflecting a decline of about 11.8%[20]. - Basic and diluted earnings per share for the current period were both -¥0.20, slightly lower than -¥0.19 in the previous period[20]. Assets and Liabilities - The total assets at the end of Q3 2024 were ¥1,882,319,033.90, down 5.78% from the end of the previous year[3]. - Total current assets as of September 30, 2024, amounted to ¥1,086,358,495.97, a decrease from ¥1,166,135,742.41 as of December 31, 2023, representing a decline of approximately 6.84%[15]. - Cash and cash equivalents decreased to ¥67,932,808.65 from ¥97,602,921.40, reflecting a decline of about 30.49%[15]. - Accounts receivable increased to ¥120,033,157.58 from ¥108,035,604.85, showing an increase of approximately 11.83%[15]. - Inventory rose to ¥17,407,503.63 from ¥15,828,142.53, indicating an increase of about 9.97%[15]. - Current liabilities decreased to CNY 154,909,408.62 from CNY 179,991,118.63, a reduction of approximately 13.9%[16]. - The total equity attributable to shareholders decreased to CNY 1,659,909,646.90 from CNY 1,736,783,386.05, a decline of about 4.4%[17]. - The company’s total liabilities and equity amounted to CNY 1,882,319,033.90, down from CNY 1,997,768,441.18, reflecting a decrease of approximately 5.8%[17]. Cash Flow - The net cash flow from operating activities for the year-to-date period was -¥6,582,776.74[2]. - The net cash flow from operating activities for the first three quarters of 2024 was approximately ¥243.93 million, an increase from ¥235.36 million in the same period of 2023, reflecting a growth of about 3.3%[21]. - The net cash flow from investing activities showed a significant decrease, with inflows of approximately ¥1.66 billion in 2024 compared to ¥2.32 billion in 2023, representing a decline of about 28.2%[22]. - The net cash flow from financing activities was negative at approximately -¥77.74 million in 2024, compared to -¥36.33 million in 2023, indicating a worsening of cash outflows[23]. - The cash outflow from operating activities totaled approximately ¥257.40 million, compared to ¥269.05 million in the previous year, showing an improvement of about 4.3%[22]. - The company reported a net increase in cash and cash equivalents of approximately -¥29.44 million for the current period, compared to -¥267.55 million in the previous period, indicating a significant improvement[23]. Research and Development - The R&D investment totaled ¥18,427,953.60 in Q3 2024, accounting for 20.94% of operating revenue, a decrease of 0.94 percentage points year-on-year[3]. - Research and development expenses were CNY 57,232,634.76, compared to CNY 58,347,615.01 in the previous year, a decrease of approximately 1.9%[19]. Shareholder Information - The top shareholder, Shanghai Dish Consulting Co., Ltd., holds 27,771,000 shares, representing 35.62% of total shares[8]. - The second-largest shareholder, Shanghai Technology Venture Capital Co., Ltd., owns 10,760,733 shares, accounting for 13.80%[8]. - The company reported a total of 6,405 common shareholders at the end of the reporting period[8]. - There are no significant changes in the shareholding structure of the top 10 shareholders compared to the previous period[12]. Government Support and Cost Management - Government subsidies recognized during the period amounted to ¥1,169,166.27, contributing positively to the financial results[4]. - The company has implemented cost control measures, resulting in a decrease in operating costs compared to the previous year[6].